Profil
Jason Carlton worked as an Executive Director of Clinical Operations at Ultragenyx Pharmaceutical, Inc. and as the Head of Global Clinical Operations at Genentech, Inc. He also worked as a Vice President of Clinical Operations at Jasper Therapeutics, Inc. for a brief period in 2022.
Mr. Carlton completed his undergraduate degree at LaSalle University.
Anciens postes connus de Jason Carlton
| Sociétés | Poste | Fin |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2022 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| ULTRAGENYX PHARMACEUTICAL INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Jason Carlton
| LaSalle University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| JASPER THERAPEUTICS, INC. | Finance |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |